| NCT ID | NCT03107533 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Scoliosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2017-03-30 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2017-03-30 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Analysis of video encounters between providers, patients, and families will be used to develop a shared decision making tool for patients deciding between surgery and observation for scoliosis treatment.
Eligibility Criteria
Inclusion Criteria: * Scoliosis curve \>40 degrees, \< 65 degrees * Risser score \> 2 * Age \> 13 years Exclusion Criteria: * Risser score of 0 or 1 * Non-ambulatory scoliosis patients * Ages 12 year and under
Contact & Investigator
Noelle Larson, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT03107533 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, studying Scoliosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03107533 currently recruiting?
Yes, NCT03107533 is actively recruiting participants. Contact the research team at severson.angela2@mayo.edu for enrollment information.
Where is the NCT03107533 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT03107533 clinical trial?
NCT03107533 is sponsored by Mayo Clinic. The principal investigator is Noelle Larson, MD at Mayo Clinic. The trial plans to enroll 25 participants.